STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
92 hedge funds and large institutions have $195M invested in Stemline Therapeutics, Inc. in 2018 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 39 increasing their positions, 19 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
31% less call options, than puts
Call options by funds: $1.6M | Put options by funds: $2.31M
42% less capital invested
Capital invested by funds: $337M → $195M (-$143M)
Holders
92
Holding in Top 10
2
Calls
$1.6M
Puts
$2.31M
Top Buyers
| 1 | +$9.41M | |
| 2 | +$2.61M | |
| 3 | +$2.36M | |
| 4 |
Axa
Paris,
France
|
+$2.18M |
| 5 |
PC
Pier Capital
Stamford,
Connecticut
|
+$1.63M |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$6.54M | |
| 3 | -$4.16M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.01M |